ZIM
AMRX icon

Zacks Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Zacks Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,625
Closed -$613K – 712
2025
Q4 		$613K Sell
48,625
-5,926
-11% -$67.8K ﹤0.01% 469
2025
Q3 		$546K Buy
54,551
+8,588
+19% +$77.1K ﹤0.01% 478
2025
Q2 		$372K Sell
45,963
-2,371
-5% -$17.9K ﹤0.01% 524
2025
Q1 		$405K Buy
+48,334
New +$403K ﹤0.01% 509
2021
Q1 		– Sell
-15,835
Closed -$72K – 496
2020
Q4 		$72K Sell
15,835
-107,941
-87% -$478K ﹤0.01% 510
2020
Q3 		$480K Sell
123,776
-3,221
-3% -$13.8K 0.01% 403
2020
Q2 		$605K Buy
+126,997
New +$523K 0.01% 372

Other funds holding AMRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return